Dayanan, Albert T.
HRN: 20-72-87 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
11/21/2023
11/27/2023
PO
400000
Q8
Oral Thrush
Checking Final Appropriateness
11/21/2023
CEFTRIAXONE 1G (VIAL)
11/21/2023
11/27/2023
IV
2g
OD
Pharyngitis; T/c Pharyngeal Abscess
Checking Final Appropriateness
11/22/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
11/22/2023
11/29/2023
IV
400 Now Then 200 OD
OD
Candidiasis
Checking Final Appropriateness
11/22/2023
AZITHROMYCIN 500MG TABLET (TAB)
11/22/2023
11/26/2023
PO
500
OD
CAP
Checking Final Appropriateness
12/01/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/01/2023
12/01/2023
IV
4.5g
Loading Dose (now)
Sepsis
Checking Final Appropriateness
12/01/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/01/2023
12/08/2023
IV
2.25g
Q8
Sepsis
Checking Final Appropriateness